RGEN
USDRepligen Corporation Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$149.060
High
$151.250
Low
$146.000
Volume
0.61M
Company Fundamentals
Market Cap
8.3B
Industry
Medical Instruments & Supplies
Country
United States
Trading Stats
Avg Volume
0.92M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Repligen Corporation to Present at Upcoming November Conferences
WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be attending five upcoming
Canaccord Genuity Maintains Hold on Repligen, Raises Price Target to $165
Canaccord Genuity analyst Kyle Mikson maintains Repligen with a Hold and raises the price target from $150 to $165.
Barclays Maintains Overweight on Repligen, Raises Price Target to $175
Barclays analyst Luke Sergott maintains Repligen with a Overweight and raises the price target from $160 to $175.
Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance
Revenue of $189 million, year-over-year increase of 22% as reported and 18% organic with double-digit reported growth across all franchisesOrders increased sequentially and greater than 20% year-over-yearIncreasing
Repligen to Report Third Quarter 2025 Financial Results
WALTHAM, Mass., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its third quarter 2025 financial results on Tuesday, October 28, 2025. The Company will
Related Stocks
FRPT
Freshpet Inc.
ONCO
Onconetix Inc.
NMTC
NeuroOne Medical Technologies Corporation
CODI
D/B/A Compass Diversified Holdings Shares of Beneficial Interest
SXTPW
60 Degrees Pharmaceuticals Inc. Warrant
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.